Researchers at the Center for Research in Biological Chemistry and Molecular Materials (CiQUS) have developed a novel chemical strategy to build biomimetic synthetic cells that can be adjusted in real-time, offering a more flexible way to mimic the complex machinery of living organisms. By utilizing reversible chemical bonds, the team has created artificial systems that can encapsulate enzymes and communicate with one another, functioning as microscopic chemical reactors.
The breakthrough, led by scientists at the University of Santiago de Compostela, addresses a long-standing hurdle in synthetic biology: the rigidity of artificial materials. Traditionally, creating a synthetic cell required a painstaking, linear process of designing, synthesizing and purifying specific polymers. If a researcher wanted to change a single property of the cell, they often had to start the entire chemical synthesis from scratch.
The CiQUS team bypassed this bottleneck by employing dynamic covalent chemistry. Instead of permanent bonds, they used boronates—chemical links that can form and break reversibly in water. This allows scientists to tweak the properties of the synthetic cell directly within the solution by adding small molecules, effectively “programming” the system’s behavior without needing to synthesize new compounds for every iteration.
Engineering the artificial cytoplasm
To replicate the internal environment of a cell, the researchers focused on creating coacervates. These are tiny, dense droplets that separate from a liquid solution, creating a concentrated environment rich in macromolecules. In the CiQUS model, a water-soluble polymer is combined with oppositely charged molecules called catechols, triggering the formation of these droplets.
“The system itself mimics the cytoplasm, as it’s rich in macromolecules,”
says researcher Bruno Delgado.
To provide structure and protection, the team encased these coacervates in an artificial membrane made from an amphiphilic copolymer. This material contains both water-attracting and water-repelling regions, allowing it to stabilize the droplet and regulate the movement of molecules in and out of the system, much like a natural lipid bilayer membrane does in human cells.
Once the structure was stabilized, the researchers introduced enzymes into the droplets. This transformed the synthetic cells into microscopic factories capable of accelerating chemical reactions. According to researcher Lucas García, “These reactors accelerate reaction kinetics and enable communication between different populations of systems,” which allows the synthetic cells to produce molecules that can trigger responses in neighboring structures.
Unexpected gains in enzyme efficiency
During the experimentation process, the team encountered a result that challenged their initial hypotheses. They introduced “dopant” molecules into the system, expecting that these additions might hinder the activity of the encapsulated enzymes by crowding the internal space.
Instead, the opposite occurred.
“We thought enzyme activity would decrease, but instead, it increased when we added dopants,”
Delgado explains.
This discovery suggests that the chemical environment within these biomimetic synthetic cells can be optimized to actually enhance biological catalysts. This level of control over internal chemical behavior is a critical step toward creating more sophisticated artificial cells that can perform complex, multi-step industrial or medical tasks.
Comparing Synthetic Construction Methods
The shift from traditional polymer synthesis to the dynamic approach used by CiQUS represents a significant change in how synthetic biology is practiced in the lab.
| Feature | Traditional Polymer Strategy | CiQUS Dynamic Strategy |
|---|---|---|
| Workflow | Linear: Design $rightarrow$ Synth $rightarrow$ Purify | Iterative: Base material $rightarrow$ In situ tweak |
| Flexibility | Low; requires new compounds for changes | High; adjusted via small-molecule additions |
| Speed | Slow; multi-step lab processing | Rapid; direct modification in solution |
| Bond Type | Permanent covalent bonds | Reversible boronate bonds |
From the lab to regenerative medicine
The implications of this research extend beyond basic chemistry. The ability to create controllable, enzyme-filled compartments opens the door to advanced biotechnological applications, particularly in the field of regenerative medicine. Because these systems can be tuned to interact with biological tissues, they may eventually be used to support the growth of synthetic tissues or assist in the differentiation of stem cells.
One of the most ambitious goals mentioned by the team is the creation of hybrid systems that combine natural and artificial cells. Such a system could potentially produce therapeutic drugs inside the body rather than simply delivering a pre-made dose.
“You could control not just the release, but the in situ production of a drug-something that hasn’t been achieved yet,”
says Delgado.
This capability would allow for highly precise medical treatments where the drug is synthesized only when and where it is needed, potentially reducing side effects and increasing the efficacy of the treatment.
The team’s findings were detailed in a study published in the Journal of the American Chemical Society, highlighting the role of dynamic covalent boronate chemistry in the optimization of cytomimetic coacervates.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. The technologies discussed are currently in the research phase and are not yet available for clinical utilize.
Moving forward, the CiQUS researchers plan to further investigate the molecular mechanisms that govern how coacervates behave and explore the creation of miniature, lab-like systems for use within the body. The next phase of their research will focus on scaling these synthetic cells into more complex tissue-like formations.
Do you believe synthetic cells will eventually replace traditional drug delivery methods? Share your thoughts in the comments or share this story on social media.
Keep reading
